X0206 3 2019-03-20 0 0000094845 LEVI STRAUSS & CO LEVI 0001472176 Singh Harmit J C/O LEVI STRAUSS & CO. 1155 BATTERY STREET SAN FRANCISCO CA 94111 0 1 0 0 Executive VP and CFO Common Stock 111980 D Stock Appreciation Rights 6.10 2023-02-09 Common Stock 976390 D Stock Appreciation Rights 7.425 2022-02-04 Common Stock 792450 D Stock Appreciation Rights 6.45 2021-02-05 Common Stock 660790 D Stock Appreciation Rights 3.775 2020-02-05 Common Stock 246210 D Stock Appreciation Rights 14.875 2029-01-29 Common Stock 89440 D Stock Appreciation Rights 9.60 2025-01-30 Common Stock 138670 D Stock Appreciation Rights 6.90 2024-02-01 Common Stock 216980 D Each share of Common Stock shall be reclassified into one share of Class B Common Stock immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock. 105,930 of the shares are represented by restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. Of the 105,930 RSUs, (i) 50,720 RSUs vest on February 1, 2020, (ii) 28,320 RSUs represent the unvested portion of an RSU award that vests in four equal annual installments beginning on January 30, 2019, and (iii) 26,890 of the RSUs vest in four equal annual installments beginning on January 30, 2020. Of these stock appreciation rights (SARs): (i) 443,810 are performance stock appreciation rights (PSARs) that vested on January 30, 2019 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors, and are immediately exercisable; and (ii) 532,580 are time-based SARs that vested as to 25% of the SARs on February 9, 2017, with the remainder vesting in 36 equal monthly installments thereafter. Each SAR represents the right to receive, upon exercise, shares of the Issuer's Common Stock with a value equal to the increase in the fair market value of one share of Common Stock from the date of grant of the SAR. Of these SARs: (i) 337,020 are PSARs that vested on January 30, 2018 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors, and are immediately exercisable; and (ii) 455,430 are time-based SARs that are fully vested. Of these SARs: (i) 220,270 are PSARs that vested on February 1, 2017 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors, and are immediately exercisable; and (ii) 440,520 are time-based SARs that are fully vested. These SARs are PSARs that vested on March 1, 2016 based upon the achievement of certain financial targets and total stockholder return, each over a three-year period, as determined by the Issuer's board of directors, and are immediately exercisable. 25% of the SARs vest on January 30, 2020, and 1/3 of the remaining SARs vest annually beginning on January 30, 2021. 25% of the SARs vested on January 30, 2019, and 1/3 of the remaining SARs vest annually beginning on January 30, 2020. 25% of the SARs vested on February 1, 2018, and 1/3 of the remaining SARs vest annually beginning on February 1, 2019. /s/ Frank Garcia, Attorney-in-Fact 2019-03-20